1. Home
  2. BCLI vs SUGP Comparison

BCLI vs SUGP Comparison

Compare BCLI & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • SUGP
  • Stock Information
  • Founded
  • BCLI 2000
  • SUGP 1998
  • Country
  • BCLI United States
  • SUGP Hong Kong
  • Employees
  • BCLI N/A
  • SUGP N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • SUGP
  • Sector
  • BCLI Health Care
  • SUGP
  • Exchange
  • BCLI Nasdaq
  • SUGP NYSE
  • Market Cap
  • BCLI 37.7M
  • SUGP 32.2M
  • IPO Year
  • BCLI N/A
  • SUGP 2024
  • Fundamental
  • Price
  • BCLI $0.35
  • SUGP $3.12
  • Analyst Decision
  • BCLI Strong Buy
  • SUGP
  • Analyst Count
  • BCLI 1
  • SUGP 0
  • Target Price
  • BCLI $2.00
  • SUGP N/A
  • AVG Volume (30 Days)
  • BCLI 488.3K
  • SUGP 45.4K
  • Earning Date
  • BCLI 08-12-2024
  • SUGP 08-02-2024
  • Dividend Yield
  • BCLI N/A
  • SUGP N/A
  • EPS Growth
  • BCLI N/A
  • SUGP N/A
  • EPS
  • BCLI N/A
  • SUGP 0.10
  • Revenue
  • BCLI N/A
  • SUGP $20,956,402.00
  • Revenue This Year
  • BCLI N/A
  • SUGP N/A
  • Revenue Next Year
  • BCLI N/A
  • SUGP N/A
  • P/E Ratio
  • BCLI N/A
  • SUGP $29.70
  • Revenue Growth
  • BCLI N/A
  • SUGP N/A
  • 52 Week Low
  • BCLI $0.13
  • SUGP $1.83
  • 52 Week High
  • BCLI $1.90
  • SUGP $5.86
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 40.33
  • SUGP N/A
  • Support Level
  • BCLI $0.33
  • SUGP N/A
  • Resistance Level
  • BCLI $0.38
  • SUGP N/A
  • Average True Range (ATR)
  • BCLI 0.03
  • SUGP 0.00
  • MACD
  • BCLI 0.00
  • SUGP 0.00
  • Stochastic Oscillator
  • BCLI 16.30
  • SUGP 0.00

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About SUGP SU GROUP HLDGS LTD

SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment.

Share on Social Networks: